Concannon Medical Limited

Registered number: 08930794

	2025	2024
	£	£
Fixed assets	2,300	2,740

Current assets	19,135	51,459
Prepayments and accrued income	191	209
Creditors: Amounts Falling Due Within One Year	(14,408 )	(16,478 )

NET CURRENT ASSETS	4,918	35,190

TOTAL ASSETS LESS CURRENT LIABILITIES	7,218	37,930

Creditors: Amounts Falling Due After More Than One Year	(2,464 )	(6,605 )
Accruals and deferred income	(1,362 )	(1,248 )

NET ASSETS	3,392	30,077

CAPITAL AND RESERVES	3,392	30,077

Notes

1. General Information

Concannon Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08930794 . The registered office is First Floor, Unit 12, Compass Point, Ensign Way, Hamble, Southampton, Hampshire, SO31 4RA.

2. Average Number of Employees

Average number of employees, including directors, during the year was: 2 (2024: 2)

3. Directors Advances, Credits and Guarantees

Included within Debtors are the following loans to directors:

	As at 1 April 2024	Amounts advanced	Amounts repaid	Amounts written off	As at 31 March 2025
	£	£	£	£	£
Dr Peter Concannon	25,070	44,335	69,405	-	-

During the year the company loaned the director £44,335 and £69,405 was repaid. The balance on the loan at the year end was £nil (2024: £25,070). Interest was charged on this loan at HMRC's official rate of 2.25% amounting to £282 (2024: £715) . The loan is repayable on demand.

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

On behalf of the board

Dr Peter Concannon

Director

27th August 2025